Scientists at Durin Technologies, Inc., and the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM) have announced a possible breakthrough in the search for a diagnostic biomarker for Parkinson's disease - a blood test that in the future may be able to detect the disease with high accuracy. In an analysis that included more than 150 blood samples, Nagele and his
team employed human protein microarrays to identify specific
autoantibody biomarkers that may be able to diagnose Parkinson’s disease
with a high level of accuracy.
No comments:
Post a Comment